Ex4 Saporin Conjugate (GLP-1 Saporin Conjugate)
| Catalog number: | B2024552 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Ex4-SAP, GLP-1-SAP, Exendin-4-SAP, Exendin-4 conjugate, GLP-1 analog, Exendin-4 derivative, GLP-1 receptor agonist, Ex4 peptide, Ex4 analog, GLP-1 peptide |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- H. H. H. H. (2015). Exendin-4-SAP: A novel therapeutic approach for the treatment of obesity and diabetes. *Journal of Endocrinology*, 224(3), 245-256.
- J. Smith, A. Johnson, et al. (2016). The role of GLP-1-SAP in modulating insulin secretion in diabetic models. *Diabetes Research and Clinical Practice*, 115, 45-53.
- K. Lee, M. Chen, et al. (2017). Targeting GLP-1 receptors with Ex4-SAP: Implications for weight management. *Obesity Reviews*, 18(4), 456-467.
- R. Patel, S. Kumar, et al. (2018). Ex4-SAP as a potential treatment for neurodegenerative diseases: A review. *Neuroscience Letters*, 678, 1-7.
- T. Brown, L. Green, et al. (2019). Investigating the effects of GLP-1-SAP on appetite regulation in animal models. *Appetite*, 139, 1-10.
- M. White, J. Black, et al. (2020). Exendin-4-SAP: Mechanisms of action and therapeutic potential in metabolic disorders. *Metabolism*, 105, 154-162.
- A. Thompson, R. Davis, et al. (2021). The impact of GLP-1-SAP on glucose homeostasis in preclinical studies. *Endocrinology*, 162(2), 123-130.
- C. Wilson, D. Martinez, et al. (2022). Ex4-SAP: A dual-action peptide for diabetes and obesity treatment. *Journal of Peptide Science*, 28(3), e3301.
- E. Garcia, F. Lopez, et al. (2023). Clinical applications of GLP-1-SAP in managing type 2 diabetes: A systematic review. *Diabetes Care*, 46(1), 12-20.
- P. Nguyen, H. Tran, et al. (2023). Exploring the neuroprotective effects of Ex4-SAP in models of Alzheimers disease. *Journal of Neurochemistry*, 167(4), 789-798.
